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Abstract
Signalling by 39–59-cyclic guanosine monophosphate (cGMP) exists in virtually all eukaryotes. In the apicomplexan parasite
Plasmodium, the cGMP-dependent protein kinase (PKG) has previously been reported to play a critical role in four key stages
of the life cycle. The Plasmodium falciparum isoform (PfPKG) is essential for the initiation of gametogenesis and for blood
stage schizont rupture and work on the orthologue from the rodent malaria parasite P. berghei (PbPKG) has shown
additional roles in ookinete differentiation and motility as well as liver stage schizont development. In the present study,
PfPKG expression and subcellular location in asexual blood stages was investigated using transgenic epitope-tagged PfPKG-
expressing P. falciparum parasites. In Western blotting experiments and immunofluorescence analysis (IFA), maximal PfPKG
expression was detected at the late schizont stage. While IFA suggested a cytosolic location, a degree of overlap with
markers of the endoplasmic reticulum (ER) was found and subcellular fractionation showed some association with the
peripheral membrane fraction. This broad localisation is consistent with the notion that PfPKG, as with the mammalian
orthologue, has numerous cellular substrates. This idea is further supported by the global protein phosphorylation pattern
of schizonts which was substantially changed following PfPKG inhibition, suggesting a complex role for PfPKG during
schizogony.
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Introduction
Malaria remains a major public health concern in Africa, Asia,
and Latin America and the global number of deaths due to
malaria was estimated to be 655,000 in 2010 [1], most of which
are children under the age of five, although new data reports up to
1.24 million deaths caused by malaria in the same year [2]. Five
unicellular parasites of the genus Plasmodium (P. falciparum, P. vivax,
P. ovale, P. malariae and P. knowlesi) can infect humans and cause
malaria, but P. falciparum is responsible for the most severe form of
the disease. In the human host, following an initial phase of
development in the liver, P. falciparum invades erythrocytes, where
it matures from a ring to a trophozoite stage and nuclear division
gives rise to the schizont stage, which releases merozoites ready to
invade new red blood cells [3]. In mammalian cells, cGMP-
signalling is involved in a broad range of cellular processes, such as
calcium homeostasis, platelet activation, phototransduction and
smooth muscle contraction [4]. In apicomplexan parasites, the
components of the cGMP-pathway, comprising the cGMP-
synthesising guanylyl cyclases and cGMP-hydrolysing phospho-
diesterases, differ in their structural and regulatory properties from
their mammalian homologues. In Plasmodium, PKG is believed to
be the primary effector molecule of cGMP. Since PKG is refractory
to gene disruption in P. falciparum (PfPKG; PlasmoDB identifier
PF3D7_1436600) and P. berghei, an essential role for the enzyme in
the asexual blood stages was assumed [5,6]. We have previously
used a chemical genetic approach to investigate PfPKG function
[5,7,8]. The trisubstituted pyrrole 4-[2-(4-fluorophenyl)-5-(1-
methylpiperidine-4-yl)-1H-pyrrol-3-yl] pyridine (compound 1) [9]
and an even more potent inhibitor, the imidazopyridine
compound 4-[7-[(dimethylamino) methyl]-2-(4-fluorophenyl) imi-
dazo[1,2-a] pyridin-3-yl] pyrimidin-2-amine (compound 2) [10]
selectively target PfPKG by virtue of their ability to utilise a unique
active site-associated pocket, conferred by an unusually small
gatekeeper residue. Use of these inhibitors in conjunction with
a transgenic P. falciparum line, rendered inhibitor-resistant by
substitution of the gatekeeper residue in the endogenous PfPKG
enzyme with a more bulky one, allowed functional analysis of this
kinase in previous studies. PfPKG was found to be essential in
triggering gametogenesis [5] and work using P. berghei parasites has
identified additional vital roles for PbPKG in ookinete differen-
tiation and motility [6] and late liver stage development [11,12]. In
the asexual blood stages of P. falciparum, PKG inhibition was found
to block schizont rupture [8]. Recently, PfPKG was reported to
regulate the initiation of the proteolytic cascade prior to egress that
involves the subtilisin-like serine protease 1 (PfSUB1) [13].
PfSUB1 is maximally expressed in late P. falciparum blood stage
schizonts [14] and localises to dense granule-like structures,
termed exonemes, that are present at the apical end of the
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individual merozoite [15]. Prior to egress, PfSUB1 is discharged
into the parasitophorous vacuole, where it proteolytically cleaves
the serine repeat antigens (PfSERAs) and components of the
merozoite surface protein 1 (PfMSP1) complex [14,16]. Processing
of PfMSP1 was found to be blocked in schizonts treated with
compound 1 [13].
Some uncertainty exists concerning the timing of expression and
activity of PfPKG in the asexual blood stages of P. falciparum, likely
due to methodological differences in the protocols used between
studies [17–19]. It has been reported that PfPKG expression at the
protein level is high in P. falciparum ring stage parasites, as well as in
gametocytes, whereas in microarray data originating from P.
falciparum strains in culture [20], as well as in the P. falciparum
RNAseq data [21], PfPKG mRNA expression peaked in the late
asexual blood stages of the parasite. Consistent with these latter
data, maximal expression of PfPKG protein was found in the late
trophozoite and schizont stage in a more recent study [8].
The apicomplexan parasites Toxoplasma gondii and Eimeria tenella
have one PKG gene copy, but due to alternative translation start
sites, each express two isoforms. While the shorter isoform is
cytosolic, the full length protein, similar to the mammalian PKG-
II, undergoes N-terminal myristoylation and palmitoylation, which
mediates membrane anchoring [9]. The Plasmodium PKG is also
encoded by a single gene, but there is no evidence of alternative
start sites and it lacks the consensus amino acid motifs required for
acylation [18]. In P. berghei, the endogenous copy of PbPKG has
previously been tagged with green fluorescent protein and the
fusion protein was found to localise to the cytosol [6]. When
PfPKG was episomally expressed in T. gondii tachyzoites, the
protein was also reported to have a cytosolic location [18]. Prior to
this study, the cellular location of PfPKG in P. falciparum had not
been examined.
Using epitope-tagged PfPKG in the present work, PfPKG
expression was found to be maximal at the late schizont stage and
appeared to have a primarily cytosolic location, but in late
schizonts, a degree of colocalisation was detected with markers of
the ER. In accordance with the microscopy results, PfPKG was
largely soluble but partly associated with the peripheral membrane
fraction in solubility assays. Treatment of schizonts with the
specific PKG inhibitor compound 2 identified several PfPKG-
dependent changes in the global protein phosphorylation pattern.
Materials and Methods
Transfection Plasmid Construction
Transfection constructs based on the pHH1 vector [22]
contained a 1.7 kbp C-terminal fragment of the PfPKG gene and
an in-frame C-terminal HA- [23] or PTP-tag [24], followed by
a 0.65 kbp fragment of the 39UTR of PfPKG. For detailed plasmid
construction see supporting information (Methods S1). Following
single crossover homologous recombination the PfPKG gene,
under the control of the endogenous promoter, was tagged at the
C-terminus and flanked by a segment of the endogenous 39
untranslated region.
P. falciparum Culture and Transfection
P. falciparum parasites of the clone 3D7 were cultivated in human
A+ erythrocytes (National Blood Transfusion Service, UK) and
RPMI 1640 medium (Invitrogen, Life Technologies) supplemen-
ted with 0.5% (w/v) albumax type II (Gibco, Invitrogen) according
to standard procedures [25]. For transfection, ring-stage parasites
were electroporated as described previously [26]. Following
approximately four weeks of positive selection with 5 nM
WR99210 (a kind gift from Jacobus Pharmaceuticals, New Jersey,
USA), transformants were subjected to three cycles of three weeks
on/off drug to encourage loss of episomal transformants and
selection of parasites in which integration had taken place.
Parasites were cloned by limiting dilution and clonal cultures
were genotyped by PCR and Southern blotting according to
standard procedures [27]. For details on primers and probes see
supporting information (Methods S1).
Preparation of Parasite Lysates and Subcellular Fractions
For analysis of the temporal PfPKG expression profile, parasites
were released with 0.15% saponin and lysed in HBS buffer
(50 mM HEPES pH 7.4, 1 mM EDTA, 1% Nonidet P-40,
10 mM NaF, 0.1 mM sodium orthovanadate, 1 mM DTT)
supplemented with 1 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml
antipain and 10 mg/ml pepstatin A and samples were subjected to
SDS-PAGE and Western blotting according to standard proce-
dures. The protocol for sequential solubilisation of parasite
proteins was adapted from [28]. Briefly, saponin-released late P.
falciparum blood stages were resuspended in hypotonic lysis buffer
(5 mM Tris-HCl pH 8.0), freeze-thawed and the supernatant
containing the soluble protein fraction was collected after
centrifugation at 16000 g for 15 minutes at 4uC. The pellet was
washed once and resuspended in 0.5 pellet volume of DNAse
digestion buffer (5 mM Tris-HCl, 10 mM MgCl2, supplemented
with DNAse I) and incubated for 10 minutes at room temperature.
0.1 M Na2CO3, pH 11.0 was added and the suspension incubated
for 30 minutes on ice and centrifuged as above. The supernatant
was saved as the peripheral membrane protein fraction. The
remaining pellet was washed and extracted with 4% SDS/0.5%
TritonX-114 in 0.56PBS to solubilise integral membrane proteins.
Buffers were supplemented with complete EDTA-free protease
inhibitor cocktail (Roche). All extractions were performed in 5
saponin pellet volumes and equal volumes of the three super-
natants were analysed by SDS-PAGE and Western blotting
according to standard procedures.
Immunofluorescent Analysis (IFA)
Standard thin blood films were fixed in 4% formaldehyde,
permeabilised in 0.1% TritonX-100 and incubated with anti-
bodies diluted in 16PBS containing 3% BSA. Slides were
mounted in Hydromount with DAPI (National Diagnostics),
before pictures were aquired on a LSM 510 Axiovert confocal
microscope (Zeiss) and analysed with LSM Image Browser
software (Zeiss).
Antibodies
The rabbit anti-human PKG (PK1018, Calbiochem) and rat
anti-HA (clone 3F10, Roche) antibodies were diluted 1:5000 for
Western blotting and 1:50 for IFA. The rabbit anti-ProtC
(ab18591-200, Abcam) was used at 1:400 in Western blots. Mouse
monoclonal anti-Pfatubulin (Tat1) (provided by Keith Gull,
University of Oxford) was used in Western blots at 1:20000.
The mouse anti-PfPMV (obtained from the Malaria Research and
Reference Reagent Resource Center, MR4) was used at 1:2500 in
Western blots and at 1:20 in IFA. The mouse anti-PfGAPDH
(obtained from Claudia Daubenberger, Swiss Tropical and Public
Health Institute) was diluted 1:20000 for Western blots and 1:1000
for IFA. In IFA, the following antibody dilutions were being used:
mouse anti-HA (clone 16B12, Convance) at 1:2000, rabbit anti-
PfGAP45 and rat anti-PfBiP (obtained from Anthony A. Holder,
NIMR) at 1:1000, rabbit anti-PfRab11A (provided by Gordon
Langley, Inserm U1016) at 1:200 and rabbit antibodies against
PfAMA1, PfSUB1 (obtained from Michael Blackman, NIMR) at
1:200. For Western blots, secondary antibodies were HRP-coupled
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goat anti-rabbit (1:6000) (Dako), goat anti-mouse (1:2500) (Dako)
and goat anti-rat-HRP (1:1000) (SC-2006, Santa Cruz). For IFA
the following secondary antibodies were used at a dilution of
1:200: Alexa Fluor 594 donkey anti-rabbit IgG with minimal
cross-reactivity (A21207, Invitrogen), Alexa Fluor 488 goat anti-rat
IgG, pre-absorbed against mouse IgG (A11006, Invitrogen), Alexa
Fluor 488 donkey anti-mouse IgG, highly cross-absorbed (A21202,
Invitrogen) and Alexa Fluor 594 goat anti-mouse IgG, highly
cross-adsorbed (A11032, Invitrogen).
Metabolic 32P-orthophosphate Labelling of P. falciparum
Schizonts
Synchronised P. falciparum schizonts were purified by magnetic
activated cell sorting (MACS) and eluted in 16Krebs buffer
(11.8 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM
MgSO4, 4.2 mM NaHCO3, 10 mM glucose, 2 mM CaCl2,
10 mM HEPES pH 7.4). Parasites were pre-treated with 4 mM
compound 2 (0.1% final DMSO) or 0.1% DMSO only, for 1 hour
and incubated for an additional hour in 16Krebs containing
50 mCi/ml 32P-orthophosphate (Perkin Elmer LAS). Schizonts
were then harvested by centrifugation and lysed in 1% NP-40 lysis
buffer. Protein samples were fractionated using anion-exchange
chromatography (A¨KTA system, GE Healthcare) and fractions
10–14 were analysed by SDS-PAGE/autoradiography.
Results
PfPKG Expression Peaks in the Late Asexual Blood Stages
of P. falciparum
P. falciparum parasites expressing triple HA- (haemagglutinin)
[23], as well as PTP- (protein C - tobacco etch virus - protein A)
[24] C-terminally-tagged PfPKG from the endogenous locus
were produced via allelic replacement. Southern blot analysis of
clones PfPKG-HA-3A and PfPKG-PTP-1A confirmed that the
plasmid had integrated through the expected single-crossover
homologous recombination event, since bands of the predicted
sizes were detected (Fig. S1). Expression of epitope-tagged
PfPKG was verified by Western blotting and epitope-tagged
proteins of the expected sizes were detected, as well as two bands
of lower molecular weight, most likely corresponding to PfPKG
degradation products (Fig. S2). The temporal expression profile
of PfPKG-HA fusion protein was investigated throughout the
asexual blood stage by Western blotting using synchronised
cultures. Samples were taken at 24 hours (mostly mid
trophozoites), 30 hours (mostly late trophozoites), 41 hours
(mostly early schizonts) and 46 hours (mostly late schizonts) post
invasion. Relative to Pfatubulin, PfPKG expression increased as
the parasites matured and peaked in late schizont stages (Fig. 1A).
A similiar expression pattern was observed for the PfPKG-PTP
fusion protein (Fig. S2).
Notably, the expression profile of epitope-tagged fusion proteins
correlated with that of wild type (WT) PfPKG detected with
a commercial PKG antibody, raised against a synthetic peptide
corresponding to the C-terminal peptide of human PKG. This
antibody detects a protein of approximately 98 kDa, correspond-
ing to WT PfPKG, as reported previously [5,18]. While the
PfPKG-PTP fusion protein was still detectable by this peptide
antibody, HA-tagging of PfPKG ablated reactivity with the
antibody (Fig. S2), possibly as a result of a masking of the epitope
by the proximal C-terminal HA-tag. This provides convincing
evidence that this mammalian PKG antibody is reacting
specifically with PfPKG in the parasite.
PfPKG is Largely Soluble, but Shows Some Association
with the Peripheral Membrane Fraction
Assessing the subcellular location of a protein kinase is an
important preliminary step to determine its function and is
relevant to the identification of potential substrates. To investigate
whether PfPKG is cytosolic or bound to membranes, sequential
extraction of parasite proteins in hypotonic, carbonate and SDS/
TX-114 buffers was performed. While hypotonic lysis solubilises
cytosolic proteins, carbonate treatment releases proteins that are
indirectly attached to membranes by e.g. binding to integral
membrane proteins, whereas integral membrane proteins are
carbonate-insoluble and remain in the membrane fraction [29].
Most of the HA-tagged PfPKG was solubilised during hypotonic
lysis (Fig. 1B), arguing for a mainly cytosolic location of the
protein. The subsequent carbonate treatment, which solubilises
peripheral membrane proteins, released virtually all of the
remaining PfPKG protein. Glyceraldehyde-3-phosphate dehydro-
genase (PfGAPDH) used as a cytosolic marker [30], was entirely
solubilised by the hypotonic lysis. Absence of PfGAPDH from the
carbonate fraction suggests that the PfPKG protein found in this
fraction reflects a true membrane association rather than carry
over or incomplete hypotonic lysis. An integral membrane protein,
the protease plasmepsin V (PfPMV) [31], which is located in the
ER-membrane, was resistant to carbonate extraction, as demon-
strated previously [31] and was solubilised upon SDS/TX-114-
extraction of the membranes after carbonate treatment.
PfPKG Location Overlaps with that of Cytoplasmic and ER
Protein Markers
The subcellular location of PfPKG was investigated by IFA
using the parasite clone PfPKG-HA-3A. Consistent with Western
blotting results, epitope-tagged PfPKG was detected most strongly
in late blood stage parasites (Fig. 1C). A diffuse pattern of relatively
low level PfPKG expression was detected in ring and early
trophozoite stages and gametocytes (Fig. 1C). Very similar results
were obtained using PfPKG-PTP-1A clones, as well as the
parental 3D7 parasites in conjunction with the commercial human
PKG-I antibody (Fig. S3). The HA/ProtC antibodies did not react
with WT 3D7 P. falciparum in IFA (Fig. S4). In very mature,
segmented schizonts, PfPKG appeared to be residing in the
cytoplasm of the individual merozoite and the staining was
maximal in the perinuclear area (Fig. 1C). To evaluate the
subcellular location of PfPKG in blood-stage parasites, dual
labelling of HA-tagged PfPKG in the PfPKG-HA-3A clone,
together with protein markers of known subcellular compartments
was performed. Significant overlap between the PfPKG-HA
staining and the pattern obtained with an antibody detecting
PfGAPDH [30] in early and late blood stage schizonts (Fig. 2A)
suggests that like PfGAPDH, PfPKG is primarily found in the
cytosol. However, the PfPKG-HA staining also partially over-
lapped with that of the ER membrane protein PfPMV [31] and
that of the ER lumen marker PfBiP (binding immunoglobulin
protein) [32], (Fig. 2B and C) in both early and late schizonts.
Downstream of the ER in the secretory pathway, the small G-
protein PfRab11A is thought to be involved in vesicle trafficking
and localises to the rhoptries and the inner membrane complex
(IMC) at the apical end of the merozoite [33]. In mature schizonts,
the location of PfPKG-HA appeared to be largely distinct from
that of PfRab11A (Fig. 2D). Furthermore, PfPKG-HA appeared to
be absent from the IMC in segmented schizonts, since no co-
localisation of the IMC marker, the glideosome associated protein
45 (PfGAP45) [34] and PfPKG-HA was observed (Fig. 2E). To
investigate PfPKG-HA location in relation to the Golgi apparatus,
Subcellular Location of PKG in P. falciparum
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a dual staining of PfPKG-HA and PfErd2 [35], was performed
and distinct staining patterns were obtained, with PfErd2 confined
to a precise punctate location reported as a single Golgi cisterna
close to the nucleus of the parasite [35] (Fig. S6).
Calculation of the Pearson coefficient [36] is used for the
quantitative evaluation of the degree of overlap between two
staining patterns. Using the Imaris image analysis software
(Bitplane) co-localisation of PfPKG-HA with the various marker
proteins was quantified as 0.286/0.652 for PfGAPDH (trophozo-
ite/schizont), 0.299/0.485 for PfPMV (trophozoite/schizont),
0.254/0.356 for PfBiP (trophozoite/schizont), 0.171 for PfRab11A
(schizont) and 0.160 for PfGAP45 (schizont) (mean Pearson
coefficients, n = 2 to 4 parasites, calculated with a 25% threshold).
In conclusion, analysis of these dual staining experiments suggests
a primarily cytosolic localisation of PfPKG, coinciding partially
with the ER.
Immunoelectron microscopy is a powerful technique used to
reveal the cellular location of a protein and was attempted with the
PfPKG-HA-3A clone in conjunction with an anti-HA antibody;
however the staining pattern was not conclusive. Gold particles
were visualised in the cytosol of the merozoite, but also adjacent to
membranes (arrowed in Fig S5). No signal was obtained in the
secondary-only control sample (data not shown).
Normal Localisation of PfGAP45, PfSUB1 and PfAMA1 in
PKG Inhibitor-treated P. falciparum Blood Stage Schizonts
Recent data showed that P. falciparum blood stage parasites that
are treated with the PKG inhibitor compound 1 develop normally
Figure 1. PfPKG expression peaks in late blood stages and is carbonate-soluble. (A) Western blots of synchronised cultures of the PfPKG-
HA-3A clone and WT parasites (3D7 clone), 24 hours (mostly mid trophozoites), 30 hours (mostly late trophozoites), 41 hours (mostly early schizonts)
and 46 hours (mostly late schizonts) post invasion were detected with anti-HA and anti-humanPKG, respectively. Blots were re-probed with an
antibody against Pfatubulin to estimate the relative total protein loading between lanes. (B) Sequential solubilisation of parasite proteins from
saponin-released late trophozoites and schizonts. S1: soluble protein fraction (5 mM Tris-HCl, freeze thaw); S2: peripheral membrane fraction
(extraction with 100 mM Na2CO3); S3: integral membrane fraction (extraction with 4% SDS/0.5% TX-114/0.56PBS). Equal volumes of the three
supernatants were analysed by SDS-PAGE and Western blots were probed for the integral membrane protein PfPMV [31], stripped and re-probed
simultaneously for PfGAPDH [30] and PfPKG-HA. Densitometric analysis of the scan of the blot presented revealed that 89.3% of PfPKG-HA is present
in fraction S1, while fractions S2 and S3 contain 9.5% and 1.2%, respectively. (C) Immunofluorescent anti-HA detection in fixed smears of erythrocytic
stages of the PfPKG-HA-3A clone. Representative images of (i) a ring stage parasite, (ii) three early trophozoites, (iii) an early schizont, (iv, v) late
schizonts (approximate hours post invasion: (i) 4–10, (ii) 20–26, (iii) 33–39, (iv, v) 45–48) and (vi) a stage III gametocyte are shown together with bright
field images (first column) and parasite nuclei stained with DAPI (second column). Bars ,5 mM.
doi:10.1371/journal.pone.0048206.g001
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up to the schizont stage, but they are unable to rupture [8]. In the
same study, the morphology of Giemsa-stained mature schizonts
after prolonged (24 h) treatment with 2 mM compound 1 was
found to be abnormal, with stronger separation of the individual
merozoites compared to untreated schizonts [8]. However,
localisation of PfMSP1 and the rhoptry neck protein 4 (PfRON4,
Pf225) in compound 1-treated parasites was found to be normal in
IFA [8]. In the present study, the location of three schizont
proteins was assessed using IFA, to further evaluate the integrity of
subcellular compartments of the blood stage schizont and
trafficking of these proteins following treatment with the PKG
inhibitor compound 1. Antibodies against the IMC marker
PfGAP45 [34], the exoneme residing PfSUB1 [14], and the
microneme marker apical membrane antigen 1 (PfAMA1) were
used. Segmented P. falciparum schizonts were treated for 6 hours
with 4 mM compound 1 prior to immunostaining. Overall, there
were no marked morphological differences (assessed by Giemsa
staining, data not shown) between treated and untreated schizonts
and all marker proteins appeared to localise normally following
compound 1-treatment (Fig. 3A), suggesting that PfPKG function
is not involved in the control of the cellular trafficking to their
respective compartments.
PfPKG-dependent Changes in the Global Protein
Phosphorylation Pattern in P. falciparum Blood Stage
Schizonts
While PfPKG inhibitor-treated schizonts appear morphologi-
cally normal, merozoite egress is blocked. To investigate the extent
of PfPKG biochemical activity at this life cycle stage, PfPKG-
dependent changes in the global protein phosphorylation profile
were revealed by analysis of metabolically 32P-orthophosphate-
labelled P. falciparum segmented asexual blood stage schizonts,
treated with 4 mM compound 2. Parasite lysates were fractionated
via ion-exchange chromatography and separated by SDS-PAGE.
Changes in the phosphorylation status of up to 20 protein bands
were seen following treatment with compound 2 in WT 3D7
parasites. These changes were not observed in compound 2-
insensitive parasites with the gatekeeper mutation (PfPKGT618Q),
a result that firstly confirms the selectivity of compound 2 for
PfPKG, but also points to a complex pattern of PfPKG-dependent
phosphorylation events. Importantly, in addition to decreases in
phosphorylation events following PfPKG inhibition with com-
pound 2, there were also increases in phosphorylation. This
complex pattern of phosphorylation changes following inhibition
of PfPKG indicates that this kinase is likely to be in a key position
in protein phosphorylation cascades. As reported previously,
PfPKG is known to undergo autophosphorylation [17,37].
However, no clearly labelled protein band at the size of PfPKG
(approximately 98 kDa [5,18]) was observed which is most likely
due to the fact that only the most abundant phosphoproteins will
be detected by autoradiography. In fraction 12, a prominent
phosphoprotein of approximately ,40 kDa was observed. While
this band may represent parasite proteins previously identified as
phosphorylated in global phospho-proteomic studies [38,39] such
as PfGAP45, 60S ribosome subunit and the 26S proteasome
regulatory subunit, the precise identity can not be determined. We
are currently attempting to identify PfPKG substrates using mass
spectrometry approaches.
Discussion
Since an important role for PfPKG in egress of merozoites from
blood stage schizonts had previously been described [8,13], this
project aimed at characterising PfPKG further by assessing the
temporal expression profile of the enzyme and its subcellular
localisation, to identify precisely when and where in the parasite
PfPKG is performing its role. Also, schizont morphology and
phosphorylation events in response to treatment with specific PKG
inhibitors were examined. In transgenic P. falciparum parasites,
HA- and PTP-tagged PfPKG expression was detectable through-
out the erythrocytic stages of the life cycle, but was found to be
maximal at the segmented schizont stage in both Western blot and
IFA. These data are in agreement with maximal PKG mRNA
expression measured in mature blood stage schizonts of Plasmodium
parasites according to available transcriptome data [20,21,40] and
are consistent with the role of PfPKG in schizont rupture [8].
Subcellular fractionation and IFA analysis suggested that
PfPKG has a primarily cytosolic location. In segmented schizonts,
PfPKG staining was maximal in the area surrounding the nuclei
and in dual staining experiments, there was marked overlap of
PfPKG-HA with the ER-marker proteins PfBiP and PfPMV. This
was reflected in a higher Pearson coeffient for these co-staining
experiments, than with, for example, PfRab11A, a marker of
vesicle trafficking [33].
The absence of the N-terminal acylation motifs in PfPKG,
which are present in Toxoplasma and Eimeria PKG orthologues,
strongly suggests that PfPKG is unlikely to be directly anchored to
parasite membranes. In the present study, solubilisation experi-
ments support this notion since carbonate extraction solubilised
HA-tagged PfPKG. While the integral membrane protein PfPMV
was found in the SDS/TX-114-fraction of membranes following
carbonate treatment, only traces of PfPKG were found in this
fraction, suggesting that the kinase does not behave as an integral
membrane protein. However, the presence of PfPKG-HA in the
peripheral membrane fraction after hypotonic lysis suggests that
the kinase may be partially associated with the membrane in late
schizonts through protein-protein interaction with a membrane-
bound protein or complex. Together with the IFA findings, this
suggests a potential location of PfPKG in the proximity of the early
secretory pathway in late stage P. falciparum schizonts and possibly
an interaction with ER membranes through an ER-localised
protein complex.
The potential role of PfPKG in regulating assembly of specific
cellular compartments in schizonts was analysed microscopically
following treatment of parasites with compound 1. Although
compound 1 inhibits P. falciparum merozoite egress, the integrity of
IMC, exonemes and micronemes appeared to be unaffected,
suggesting that the block likely occurs after differentiation of these
cellular compartments. This is interesting, since it was recently found
that PfPKG function is required for successful processing of PfMSP1
byPfSUB1[13]. Inconjunctionwith thepresent results, it is tempting
tospeculate thatPfPKGregulates theactivationorreleaseofPfSUB1,
rather than its cellular trafficking to the exonemes. The previously
reported effect of greater separation of P. falciparum merozoites in
Figure 2. Subcellular location of PfPKG in mature schizonts. Dual immunofluorescent detection of PfPKG-HA in fixed smears of early and late
schizonts of the PfPKG-HA-3A clone together with (A) PfGAPDH [30], (B) PfBiP [32], (C) PfPMV [31], (D) PfRab11A [33] and (E) PfGAP45 [34].
Representative images are shown for each antibody, together with bright field images (first column) and parasite nuclei stained with DAPI (in the
merged image). Bars ,5 mM. To quantify co-localisation, Pearson coefficients [36] of the individual stains were calculated using Imaris image analysis
software (Bitplane).
doi:10.1371/journal.pone.0048206.g002
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schizonts after compound treatment [8] was not observed in the
present study,where treatment timewas6hours rather than24hours
[8]. This longer treatment exposed schizonts that are mature, but
unable to egress, to the drug in culture for several hours, most likely
accounting for the stronger morphological differences between
treated and untreated schizonts.
Figure 3. Parasite morphology and global protein phosphorylation pattern of PKG inhibitor-treated P. falciparum schizonts. (A)
Immunofluorescent staining of DMSO/compound 1-treated WT schizonts using antibodies detecting (i) PfGAP45 [34], (ii) PfSUB1 [14] and (iii) PfAMA1
[23]. Representative images are shown for each staining together with parasite nuclei stained with DAPI. Bars ,5 mM. (B) Metabolic labelling of
phosphoproteins in P. falciparum schizonts. Autoradiographs of (i) 3D7 WT and (ii) gatekeeper mutant 3D7 PfPKGT618Q schizonts, treated with
32P-
orthophosphate and DMSO (2) or compound 2 (+) prior to lysis, A¨KTA anion exchange chromatography (fractions 10–14 are shown) and separation
by SDS-PAGE. Rectangular boxes highlight bands that show a differential signal following inhibitor-treatment in WT, but not PfPKGT618Q schizonts.
doi:10.1371/journal.pone.0048206.g003
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Analysis of the global phospho-proteome using fractionation of
metabolically labelled parasites treated with compound 2 indicated
that inhibition of PfPKG resulted in changes in the phosphory-
lation status of over 20 parasite proteins. The changes observed in
the phosphoproteome following PfPKG inhibition were seen to be
complex, with both increases as well as decreases in phosphory-
lation. Notably very few changes were seen in parasites expressing
the inhibitor insensitve PfPKGT618Q mutant, indicating that
compound 2 had few off-target effects. The expression and sub-
cellular localisation data reported here are consistent with a role
for PfPKG in egress and the extensive impact of inhibition of
PfPKG on the phospho-proteome indicates that this kinase likely
has a complex interaction network to effect its role in schizont
rupture and merozoite egress.
Supporting Information
Figure S1 Endogenous tagging of the PfPKG locus by
allelic replacement. (A) Allelic replacement strategy.
Schematic representations of transfection plasmids and the PfPKG
loci before and after individual integration of the tagging
constructs (i, ii) are shown. The C-terminal 1.7 kbp of the PfPKG
gene (grey shaded area) facilitated integration by single crossover
homologuous recombination and was followed by the PTP2/HA-
tag (striped/dotted area) and the 0.65 kbp fragment of the PfPKG
39UTR. Arrowheads indicate primer binding sites. EcoRI and XbaI
restriction sites (E and Xb), as well as hybridisation sites of
Southern blotting probes to PfPKG (line) and hDHFR (dashed line)
are shown. Integration of two plasmid copies into the PfPKG locus
is depicted. (B) PCR analysis of transfected cultures
confirming integration. The 59 crossover junction was
analysed by PCR using a 59 primer hybridising to the PTP- and
HA-tag, respectively and a 39 primer bound the PfPKG locus
upstream of the 1.7 kbp fragment that is present in the plasmid
(for primer binding sites see arrowheads in (A)). Products can only
be amplified in case of integration of the construct. Parental WT
3D7 parasite gDNA was used as a negative control for each primer
set (PTP, HA). Sizes of obtained PCR products were as expected:
2.3 kbp (PfPKG-PTP), 1.9 kbp (PfPKG-HA). (C) Southern blot
analysis of gDNA from cloned parasite lines. gDNA was
digested with EcoRI and XbaI respectively. The PfPKG fragments
detected were as expected for parental WT 3D7 (12.3 kbp) and
PfPKG-PTP-1A (9.6 kb, 4.4 kbp and 6.3 kbp) and PfPKG-HA-
3A (12.7 kbp, 7.8 kbp and 6.3 kbp) parasites. Presence of bands of
the plasmid size (4.4 kbp in the PfPKG-PTP-1A parasites and
7.8 kbp in the PfPKG-HA-3A parasites) indicated that integration
of more than one plasmid copy had occurred and elevated
intensity of those plasmid bands suggested integration of multiple
copies, a phenomenon which has previously been documented
[14] and is not surprising, since plasmid copy numbers exceed the
number of genomes during recombination [26]. Fragments of the
hDHFR locus were 0.8 kbp and 1.7 kbp, as expected. Growth rate
compared to the parental 3D7 line was not measured, but cloned
lines displayed no evident growth defect upon daily culturing.
(TIF)
Figure S2 Transgenic P. falciparum lines express
tagged PfPKG. Western blots of late blood stages of PfPKG-
PTP-1A and PfPKG-HA-3A parasite clones and parental WT
parasites of the 3D7 clone were probed with antibodies against (A)
ProtC, (B) HA and (C) humanPKG. The epitope-tagged forms of
PfPKG-PTP and PfPKG-HA, as well as two bands of lower
molecular weight, most likely corresponding to PfPKG degrada-
tion products, are only detected in the corresponding clones, but
not in the WT parasites. The human PKG antibody detects the
WT PfPKG and the PfPKG-PTP fusion protein, but does not
react with the epitope-tagged PfPKG-HA. The size-shift of tagged
PfPKG species compared to the parental WT PfPKG (97.7 kDa) is
consistent with the 18.7 kDa mass of the PTP-tag and 3.3 kDa for
the HA-tag, which results in a total size of 116.4 kDa for PfPKG-
PTP and 100.9 kDa for the PfPKG-HA fusion protein. As
a protein loading control, Pfatubulin was detected using a mouse
monoclonal antibody (Tat1). (D) Western blot of synchronised
parasite cultures of the clone PfPKG-PTP-1A 24 hours (mostly
mid trophozoites), 30 hours (mostly late trophozoites), 41 hours
(mostly early schizonts) and 46 hours (mostly late schizonts) post
invasion was detected with anti-ProtC and re-probed with an
antibody against Pfatubulin to estimate the relative total protein
loading between lanes.
(TIFF)
Figure S3 IFA of PfPKG in PfPKG-PTP-1A and WT 3D7
lines. Immunofluorescent detection using antibodies against (A)
human PKG on WT parasites of the 3D7 clone and (B) ProtC on
parasites of the PfPKG-PTP-1A clone. Representative images of (i)
a ring stage parasite, (ii) two early trophozoites, (iii) an early
schizont, (iv, v) late schizonts and (vi) a stage III gametocyte are
shown together with bright field images (first column) and parasite
nuclei stained with DAPI (second column). Bars ,5 mM.
(TIF)
Figure S4 Negative control IFA. Immunofluorescent staining
of WT parasites (clone 3D7) with (A) the rat HA-antibody, (B) the
mouse HA-antibody and (C) the rabbit ProtC-antibody. Repre-
sentative IFA images are shown together with bright field images
(first column) and parasite nuclei stained with DAPI (second
column). Bars ,5 mM.
(TIF)
Figure S5 Dual staining of PfPKG-HA together with
PfERD2. Dual staining of PfPKG-HA in fixed smears of early
and late schizonts of the PfPKG-HA-3A clone together with
PfErd2 [35]. Representative images are shown, together with
bright field images (first column) and parasite nuclei stained with
DAPI (in the merged image). Bars ,5 mM.
(TIF)
Figure S6 Immunoelectron microscopic visualisation of
PfPKG-HA-3A. Segmented schizonts of the PfPKG-HA-3A
clone were fixed in formaldehyde/glutaraldehyde and mounted
in LR white resin. PfPKG-HA was detected with mouse HA
antibody; secondary detection was performed with 10 nM gold
particle-coupled anti-mouse antibody. Sections were counter-
stained with uranyl acetate and images were captured digitally
on a Jeol JEM –1200EX II electron microscope. Bars 500 nm.
(TIF)
Methods S1 Additional details of experimental procedures.
(DOCX)
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